Cargando…

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

Merkel cell carcinoma (MCC) is an aggressive malignancy with neuroendocrine (NE) features, limited treatment options, and a lack of druggable targets. There is no reported involvement of the MUC1-C oncogenic protein in MCC progression. We show here that MUC1-C is broadly expressed in MCCs and at hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morimoto, Yoshihiro, Fushimi, Atsushi, Yamashita, Nami, Hagiwara, Masayuki, Bhattacharya, Atrayee, Cheng, Jingwei, Frost, Thomas C., Ahmad, Rehan, Daimon, Tatsuaki, Huang, Lei, Hata, Tsuyoshi, Takahashi, Hidekazu, Yamamoto, Masaaki, Suzuki, Yozo, DeCaprio, James A., Kufe, Donald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9249628/ https://www.ncbi.nlm.nih.gov/pubmed/35688945 http://dx.doi.org/10.1038/s41388-022-02361-3

Ejemplares similares

MUC1-C is a master regulator of MICA/B NKG2D ligand and exosome secretion in human cancer cells
por: Morimoto, Yoshihiro, et al.
Publicado: (2023)

Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer
por: Yamashita, Nami, et al.
Publicado: (2022)

MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression
por: Bhattacharya, Atrayee, et al.
Publicado: (2023)

MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
por: Yamashita, Nami, et al.
Publicado: (2021)

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas
por: Luan, Zhou, et al.
Publicado: (2021)

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
por: Yamashita, Nami, et al.
Publicado: (2023)

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells
por: Yamashita, Nami, et al.
Publicado: (2023)

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non–neuroendocrine Small Cell Lung Cancer
por: Fushimi, Atsushi, et al.
Publicado: (2022)

MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells
por: Bhattacharya, Atrayee, et al.
Publicado: (2022)

MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells
por: Hagiwara, Masayuki, et al.
Publicado: (2021)

MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer
por: Hagiwara, Masayuki, et al.
Publicado: (2022)

Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression
por: Yamashita, Nami, et al.
Publicado: (2022)

The Merkel Cell Polyomavirus T Antigens Function as Tumor Promoters in Murine Skin
por: Spurgeon, Megan E., et al.
Publicado: (2021)

Merkel Cell Polyomavirus: Oncogenesis in a Stable Genome
por: Ahmed, Mona M., et al.
Publicado: (2021)

Does a new polyomavirus contribute to Merkel cell carcinoma?
por: Garneski, Kelly M, et al.
Publicado: (2008)

MUC1-C ACTIVATES THE TAK1 INFLAMMATORY PATHWAY IN COLON CANCER
por: Takahashi, Hidekazu, et al.
Publicado: (2015)

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2020)

MUC1-C ACTIVATES BMI1 IN HUMAN CANCER CELLS
por: Hiraki, Masayuki, et al.
Publicado: (2016)

Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2020)

YAP1 and WWTR1 expression inversely correlates with neuroendocrine markers in Merkel cell carcinoma
por: Frost, Thomas C., et al.
Publicado: (2023)

Merkel cell polyomavirus large T antigen binding to pRb promotes skin hyperplasia and tumor development
por: Spurgeon, Megan E., et al.
Publicado: (2022)

Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma
por: Starrett, Gabriel J., et al.
Publicado: (2017)

Milademetan is a highly potent MDM2 inhibitor in Merkel cell carcinoma
por: Ananthapadmanabhan, Varsha, et al.
Publicado: (2022)

Merkel Cell Polyomavirus Small T Antigen Promotes Pro-Glycolytic Metabolic Perturbations Required for Transformation
por: Berrios, Christian, et al.
Publicado: (2016)

Predictors of immunotherapy benefit in Merkel cell carcinoma
por: Kacew, Alec J., et al.
Publicado: (2020)

The biology and treatment of Merkel cell carcinoma: current understanding and research priorities
por: Harms, Paul W., et al.
Publicado: (2018)

Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells
por: Alam, Maroof, et al.
Publicado: (2014)

MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells
por: Kosugi, Michio, et al.
Publicado: (2011)

Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells
por: Hasegawa, Masanori, et al.
Publicado: (2016)

Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia
por: Kufe, Donald W.
Publicado: (2022)

Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer
por: Kufe, Donald
Publicado: (2023)

COOPERATIVITY OF THE MUC1 ONCOPROTEIN AND STAT1 PATHWAY IN POOR PROGNOSIS HUMAN BREAST CANCER
por: Khodarev, Nikolai, et al.
Publicado: (2009)

DNA METHYLATION BY DNMT1 AND DNMT3b METHYLTRANSFERASES IS DRIVEN BY THE MUC1-C ONCOPROTEIN IN HUMAN CARCINOMA CELLS
por: Rajabi, Hasan, et al.
Publicado: (2016)

Integrative analysis reveals therapeutic potential of pyrvinium pamoate in Merkel cell carcinoma
por: Yang, Jiawen, et al.
Publicado: (2023)

MUC1-C REPRESSES THE RASSF1A TUMOR SUPPRESSOR IN HUMAN CARCINOMA CELLS
por: Rajabi, Hasan, et al.
Publicado: (2019)

Targeting the epigenetic addiction of Merkel cell carcinoma
por: Mauri, Federico, et al.
Publicado: (2020)

Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma
por: Starrett, Gabriel J., et al.
Publicado: (2020)

MUC1-C drives DNA methylation in cancer
por: Rajabi, Hasan, et al.
Publicado: (2016)

MUC1-C Stabilizes MCL-1 in the Oxidative Stress Response of Triple-Negative Breast Cancer Cells to BCL-2 Inhibitors
por: Hiraki, Masayuki, et al.
Publicado: (2016)

An analysis of the use of targeted therapies in patients with advanced Merkel cell carcinoma and an evaluation of genomic correlates of response
por: Knepper, Todd C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rlnh2q3c5obis9ii9m7cj6sr1f